Literature DB >> 28388602

Maturational decrease of glutamate in the human cerebral cortex from childhood to young adulthood: a 1H-MR spectroscopy study.

Mami Shimizu1, Yuji Suzuki1, Kenichi Yamada1, Satoshi Ueki1, Masaki Watanabe1, Hironaka Igarashi1, Tsutomu Nakada1.   

Abstract

BackgroundThe aim of the present study was to investigate maturational changes in glutamate (Glu) in the human cerebral cortex from childhood to young adulthood using 3.0-Tesla proton magnetic resonance spectroscopy (1H-MRS), which is capable of quantifying Glu in vivo.MethodsNormal volunteers comprising 11 children (aged 4-13 years) and 11 young adults (aged 18-33 years) participated in the study. Single-voxel point-resolved spectroscopy (PRESS, repetition time/echo time=2,000/80 ms) was performed on the frontal and occipital cortices, and the Glu-to-creatine ratio (Glu/Cr) and N-acetylaspartate-to-creatine ratio (NAA/Cr) were determined.ResultsIn both the frontal and occipital cortices, Glu/Cr was significantly lower during young adulthood relative to that during childhood. NAA/Cr did not differ significantly between the two age groups.ConclusionThis study has provided objective evidence that cerebral cortical Glu/Cr decreases between childhood and young adulthood. The observed decrease in Glu/Cr may reflect the simultaneous occurrence of maturational changes, such as changes in cortical microstructure and the intercellular compartmentation of Glu metabolism.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28388602     DOI: 10.1038/pr.2017.101

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  23 in total

1.  Absolute eigenvalue diffusion tensor analysis for human brain maturation.

Authors:  Yuji Suzuki; Hitoshi Matsuzawa; Ingrid L Kwee; Tsutomu Nakada
Journal:  NMR Biomed       Date:  2003-08       Impact factor: 4.044

2.  NMDA receptor agonist and antagonists alter retinal ganglion cell arbor structure in the developing frog retinotectal projection.

Authors:  H T Cline; M Constantine-Paton
Journal:  J Neurosci       Date:  1990-04       Impact factor: 6.167

3.  In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy.

Authors:  Rachelle Crescenzi; Catherine DeBrosse; Ravi Prakash Reddy Nanga; Sanjana Reddy; Mohammed Haris; Hari Hariharan; Michiyo Iba; Virginia M Y Lee; John A Detre; Arijitt Borthakur; Ravinder Reddy
Journal:  Neuroimage       Date:  2014-07-05       Impact factor: 6.556

4.  Regional and developmental variations in metabolite concentration in the rat brain and eye: a study using 1H NMR spectroscopy and high performance liquid chromatography.

Authors:  C L Florian; S R Williams; K K Bhakoo; M D Noble
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

5.  Increase in glutamate as a sensitive indicator of extracellular matrix integrity in peritumoral edema: a 3.0-tesla proton magnetic resonance spectroscopy study.

Authors:  Teruo Kimura; Masaki Ohkubo; Hironaka Igarashi; Ingrid L Kwee; Tsutomu Nakada
Journal:  J Neurosurg       Date:  2007-04       Impact factor: 5.115

6.  Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain.

Authors:  M S van der Knaap; J van der Grond; P C van Rijen; J A Faber; J Valk; K Willemse
Journal:  Radiology       Date:  1990-08       Impact factor: 11.105

7.  Regional differences in synaptogenesis in human cerebral cortex.

Authors:  P R Huttenlocher; A S Dabholkar
Journal:  J Comp Neurol       Date:  1997-10-20       Impact factor: 3.215

8.  In vivo quantitative proton MRSI study of brain development from childhood to adolescence.

Authors:  Alena Horská; Walter E Kaufmann; Larry J Brant; Sakkubai Naidu; James C Harris; Peter B Barker
Journal:  J Magn Reson Imaging       Date:  2002-02       Impact factor: 4.813

9.  Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: immunogold evidence from hippocampal slice cultures.

Authors:  J H Laake; T A Slyngstad; F M Haug; O P Ottersen
Journal:  J Neurochem       Date:  1995-08       Impact factor: 5.372

10.  Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy.

Authors:  R Kreis; T Ernst; B D Ross
Journal:  Magn Reson Med       Date:  1993-10       Impact factor: 4.668

View more
  5 in total

1.  Diminished reward responsiveness is associated with lower reward network GluCEST: an ultra-high field glutamate imaging study.

Authors:  Valerie J Sydnor; Bart Larsen; Christian Kohler; Andrew J D Crow; Sage L Rush; Monica E Calkins; Ruben C Gur; Raquel E Gur; Kosha Ruparel; Joseph W Kable; Jami F Young; Sanjeev Chawla; Mark A Elliott; Russell T Shinohara; Ravi Prakash Reddy Nanga; Ravinder Reddy; Daniel H Wolf; Theodore D Satterthwaite; David R Roalf
Journal:  Mol Psychiatry       Date:  2021-01-21       Impact factor: 13.437

2.  Dyslexia and age related effects in the neurometabolites concentration in the visual and temporo-parietal cortex.

Authors:  Bartosz Kossowski; Katarzyna Chyl; Agnieszka Kacprzak; Piotr Bogorodzki; Katarzyna Jednoróg
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

3.  Longitudinal GluCEST MRI Changes and Cerebral Blood Flow in 5xFAD Mice.

Authors:  Hironaka Igarashi; Satoshi Ueki; Hiroki Kitaura; Tae Kera; Ken Ohno; Masaki Ohkubo; Mika Terumitsu-Tsujita; Akiyoshi Kakita; Ingrid L Kwee
Journal:  Contrast Media Mol Imaging       Date:  2020-11-25       Impact factor: 3.161

4.  Application of 7 tesla magnetic resonance imaging for pediatric neurological disorders: Early clinical experience.

Authors:  Kenichi Yamada; Junichi Yoshimura; Masaki Watanabe; Kiyotaka Suzuki
Journal:  J Clin Imaging Sci       Date:  2021-12-02

Review 5.  GABA and glutamate in the preterm neonatal brain: In-vivo measurement by magnetic resonance spectroscopy.

Authors:  Sudeepta K Basu; Subechhya Pradhan; Adre J du Plessis; Yehezkel Ben-Ari; Catherine Limperopoulos
Journal:  Neuroimage       Date:  2021-05-28       Impact factor: 6.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.